Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Young Children

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.754
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Subjects With and Without Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Efficacy and Safety of Long-Term Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy With Viaskin® Peanut: Results of the Two-Year Extension of the Vipes Phase IIb Clinical Trial

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

AR101 Oral Immunotherapy for Peanut Allergy

Pediatrics
Child HealthPediatricsPerinatology
2019English

Peanut Allergy and Oral Immunotherapy

Hong Kong Medical Journal
Medicine
2019English

Evaluation of Peanut Sublingual Immunotherapy for Peanut Allergy: A Pilot Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Oral Immunotherapy to Peanut in Children With Mild and Moderate Peanut Allergy Results in Long Term Tolerance

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Mannosylated Nanoparticles for Oral Immunotherapy in a Murine Model of Peanut Allergy

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2019English

Unique Epigenetic Signature in T Cell Compartment After Epicutaneous Immunotherapy in Peanut Sensitized Mice

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Intralymphatic Immunotherapy for Peanut Allergy: A Pilot Study of Three Patients

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy